Evidence map›Paper›PMID 37743510›Full record

ArticleInternal medicine (Tokyo, Japan)2024

Lambert-Eaton Myasthenic Syndrome Complicated by Anti-GABA

Kazuki Yamada, Hiroaki Yaguchi, Kaede Ishikawa, Daiki Tanaka, Yuki Oshima, Keiichi Mizushima, Hisashi Uwatoko, Shinichi Shirai, Ikuko Takahashi-Iwata, Masaaki Matsushima and 2 more

Open access · diamondAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Kazuki YamadaDepartment of Neurology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Japan.
Hiroaki YaguchiDepartment of Neurology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Japan.
Kaede IshikawaDepartment of Neurology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Japan.
Daiki TanakaDepartment of Neurology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Japan.
Yuki OshimaDepartment of Neurology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Japan.
Keiichi MizushimaDepartment of Neurology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Japan.
Hisashi UwatokoDepartment of Neurology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Japan.
Shinichi ShiraiDepartment of Neurology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Japan.
Ikuko Takahashi-IwataDepartment of Neurology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Japan.
Masaaki MatsushimaDepartment of Neurology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Japan.
Keiko TanakaDepartment of Animal Model Development, Brain Research Institute, Niigata University, Japan.
Ichiro YabeDepartment of Neurology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Japan.
Hokkaido University · JPNiigata University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 74-year-old man experienced diplopia, generalized muscle weakness, and acute respiratory failure. He was diagnosed with Lambert-Eaton myasthenic syndrome (LEMS) and treated with immunotherapy, but no improvement was observed, and additional symptoms, including central apnea and hallucinations, appeared. Subsequent serum and cerebrospinal fluid (CSF) analyses confirmed the presence of GABA

Indexed as

AutoantibodiesLambert-Eaton Myasthenic SyndromeReceptors, GABA-BAgedEncephalitisHumansMaleSmall Cell Lung CarcinomaAutoantibodiesReceptors, GABA-Bautoimmune encephalitiscentral apneaGABAB receptor antibodiesLambert-Eaton myasthenic syndrome (LEMS)

Identifiers

PMID37743510
PMCPMC11116022
OpenAlexW4386919441

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.